基于VOSviewer和CiteSpace的甘松研究热点和趋势可视化分析*
作者:陈佳凡1,成 涛2,贾博超2,段城林2,杜宜航1,冯美玉3,柴若宁1,褚瑜光1,胡元会1
单位:1.中国中医科学院广安门医院,北京 100053; 2.北京中医药大学,北京 100029; 3.山东第一医科大学,山东 济南 250022
引用:引用:陈佳凡,成涛,贾博超,段城林,杜宜航,冯美玉,柴若宁,褚瑜光,胡元会.基于VOSviewer和CiteSpace的甘松研究热点和趋势可视化分析[J].中医药导报,2025,31(12):229-239,260.
DOI:10.13862/j.cn43-1446/r.2025.12.037
PDF:
下载PDF
摘要:目的:运用文献计量学软件VOSviewer和CiteSpace对甘松的研究热点及发展趋势进行可视化分析。方法:以甘松为主题词,系统检索中国知网(CNKI)和Web of Science(WOS)核心合集数据库中的相关研究文献,检索时间自建库至2024年6月30日,借助VOSviewer、CiteSpace、Excel软件分别对甘松中、英文文献的发文量、核心作者群、机构及国家分布、期刊和被引文献、关键词特征等进行分析,并绘制可视化知识图谱。结果:共纳入文献1 108篇,涵盖中文文献898篇,英文文献210篇。甘松年发文量总体呈波动增长趋势,共有37个国家参与甘松的研究,其中以中国为主。中文文献发文量最多的作者是南一和袁玲,英文文献发文量最多的作者是Wu Honghua;北京中医药大学和中国科学院发文量分别居于中、英文文献发文量首位,各研究机构及团队间的交流合作有待进一步深化。中、英文关键词共现、聚类分析结果表明,当前甘松研究主要集中于化学成分、药理作用、临床应用和机制研究等方向。其中,中文文献侧重甘松的心脏保护作用及复方配伍研究,英文文献关注甘松的药物活性成分及神经药理机制。结论:甘松研究目前仍处于上升阶段,结合网络药理学及组学技术等的多靶点机制研究、药代动力学及毒理学研究、新产品开发、人工栽培技术优化及替代资源的挖掘等是甘松未来研究的新方向。
关键词:甘松;文献计量学;VOSviewer;CiteSpace;倍半萜类化合物;挥发油
Abstract:
Objective: To conduct a visualized analysis of research hotspots and development trends of Gansong (Nardostachydis Radix et Rhizoma) by using bibliometric software VOSviewer and CiteSpace. Methods: Taking Gansong (Nardostachydis Radix et Rhizoma) as the subject term, relevant research literatures were systematically retrieved from China National Knowledge Infrastructure (CNKI) and Web of Science (WOS) Core Collection databases from the database inception to June 30, 2024. With the assistance of VOSviewer, CiteSpace and Excel software, the number of published papers, core author groups, institutional and national distributions, journals and cited literatures, and keyword characteristics of Chinese and English literatures on Gansong (Nardostachydis Radix et Rhizoma) were analyzed respectively, and visualized knowledge maps were drawn. Results: A total of 1,108 literatures were included, covering 898 Chinese literatures and 210 english literatures. The annual number of publications on Gansong (Nardostachydis Radix et Rhizoma) showed an overall fluctuating growth trend, and 37 countries participated in the research, among which China was the main contributor. The authors with the largest number of publications in Chinese literatures were NAN Yi and YUAN Ling, while the author with the most publications in english literatures was Wu Honghua. Beijing University of Chinese Medicine and Chinese Academy of Sciences ranked first in the number of publications in Chinese and english literatures respectively, and the exchange and cooperation among various research institutions and teams need to be further strengthened. The results of co-occurrence and cluster analysis of Chinese and english keywords showed that current research on Gansong (Nardostachydis Radix et Rhizoma) mainly focused on chemical components, pharmacological effects, clinical applications and mechanism research. Among them, Chinese literatures focused on the cardioprotective effect and compound compatibility of Gansong (Nardostachydis Radix et Rhizoma), while english literatures paid attention to the active pharmaceutical ingredients and neuropharmacological mechanisms of Gansong (Nardostachydis Radix et Rhizoma). Conclusion: The research on Gansong (Nardostachydis Radix et Rhizoma) is still in an ascending stage. Multi-target mechanism research combined with network pharmacology and omics technologies, pharmacokinetic and toxicological research, new product development, optimization of artificial cultivation technology and exploration of alternative resources will be the new directions for the research of Gansong (Nardostachydis Radix et Rhizoma).
Key words:Gansong (Nardostachydis Radix et Rhizoma); bibliometrics; VOSviewer; CiteSpace; sesquiterpenoids; volatile oil
发布时间:2025-12-31
点击量:5